NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Nkarta, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$1.75−0.05 (-2.78%)
Close on Oct 19, 2026
- Market cap
- $130.37M
- P/E (TTM)
- –
- Dividend yield
- 0.00%